French pharmaceutical logistics and healthcare group CFAO Healthcare is seeking to acquire a controlling stake in Namibian pharmaceutical wholesaler Nampharm in a move that could strengthen its footprint in Namibia’s healthcare distribution market.
The proposed transaction will see CFAO Healthcare acquire control of Nampharm, a major supplier of pharmaceutical, consumer healthcare, surgical and clinical products to both private and public healthcare facilities in Namibia.
Nampharm operates as a full-line pharmaceutical wholesaler and distributor, supplying medicines, consumer healthcare products, surgical equipment, dental products and clinical supplies across the country.
CFAO Healthcare, which is incorporated in France, operates across more than 24 countries in Sub-Saharan Africa and six French overseas territories.
The company specialises in pharmaceutical logistics and cold-chain distribution systems aimed at preserving medicines and healthcare products throughout the supply chain.
The company is also involved in pharmaceutical manufacturing and healthcare innovation and holds manufacturing licences in several African markets.
Although CFAO Healthcare does not currently control any companies incorporated in Namibia within the pharmaceutical sector, it already has indirect exposure to the country through other business divisions linked to the wider CFAO Group.
The group’s mobility division operates vehicle rental services locally through CFAO Motors Rental Namibia and CFAO Motors Shuttle Service Namibia, trading as Hertz Namibia.
CFAO is also active in Namibia’s industrial sector through CFAO Equipment, which supplies material handling and warehousing equipment.
The proposed acquisition comes as pharmaceutical supply chains and healthcare logistics across Africa continue to attract growing investor interest amid rising healthcare demand, expanding urban populations and pressure on regional medicine distribution systems.
